The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-198901000-00037PMID 2643225
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BLOCKING OF T CELL ACTIVATION AT THE G1A/G1B INTERFACE OF THE CELL CYCLE AND PREVENTION OF EXPRESSION OF INTERLEUKIN 2 RECEPTORS BY ALLOACTIVATED SUPPRESSOR T LYMPHOCYTES

  1988cited by this paper
• Effect of blood transfusions on immune function. III. Alterations in macrophage arachidonic acid metabolism.

  1987cited by this paper
• The effect of donor specific transfusions and dietary fatty acids on rat cardiac allograft survival.

  1987cited by this paper
• Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.

  1985cited by this paper
• ROLE OF IA‐POSITIVE CELLS IN THE BENEFICIAL EFFECT OF DONOR BLOOD TRANSFUSION AND INDUCTION OF SUPPRESSOR CELLS IN CARDIAC ALLOTRANSPLANTATION OF RATS

  1984cited by this paper
• THE EFFECT OF DONOR‐SPECIFIC TRANSFUSIONS ON RAT HEART ALLOGRAFT SURVIVAL

  1984cited by this paper
• Eicosanoids and organ transplantation.

  1984cited by this paper
• PROSTAGLANDIN AS AN EFFECTIVE ANTIREJECTION THERAPY IN RAT RENAL ALLOGRAFT RECIPIENTS

  1983cited by this paper
• Blood transfusions, suppressor T cells, and renal transplant survival.

  1983cited by this paper
• Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.

  1983cited by this paper
• Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine.

  1983cited by this paper
• Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation.

  1983cited by this paper
• A POTENTIAL SYNERGISTIC EFFECT OF DONOR ANTIGENIC EXTRACTS AND CYCLOSPORINE ON THE PROLONGATION OF RAT RENAL ALLOGRAFTS

  1983cited by this paper
• Prostaglandins modulate macrophage Ia expression

  1982cited by this paper
• Prostaglandin E inhibits the production of human interleukin 2

  1982cited by this paper
• Effect of cyclosporin A on human lymphocyte responses in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CsA-treated primary MLR cultures.

  1982cited by this paper
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

  1981cited by this paper
• Cyclosporin-A--present experimental status.

  1981cited by this paper
• INDUCTION OF SUPPRESSOR CELLS BY DONOR‐SPECIFIC BLOOD TRANSFUSIONS AND HEART TRANSPLANTATION IN RATS

  1981cited by this paper
• Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination.

  1981cited by this paper
• Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.

  1980cited by this paper
• Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach

  1980cited by this paper
• IMMUNOSUPPRESSION WITH POLYUNSATURATED FATTY ACIDS IN RENAL TRANSPLANTATION

  1977cited by this paper
• EFFECT OF POLYUNSATURATED FATTY ACIDS ON SKIN ALLOGRAFT SURVIVAL AND PRIMARY AND SECONDARY CYTOTOXIC RESPONSE IN MICE

  1976cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper

• Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations. Cooperative Clinical Trial in Transplantation Research Group.

  1999cites this paper
• Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.

  1999cites this paper
• Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study.

  1998cites this paper
• Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.

  1997cites this paper
• Donor-specific transfusion under the new cyclosporine A formulation Consupren versus azathioprine, Imuran.

  1997cites this paper
• An examination of tissue chimerism in the ACI to Lewis rat cardiac transplant model.

  1996cites this paper
• Alloantibody and intragraft cellular response to MHC class I-disparate kidney allografts in recipients tolerized by donor-specific transfusion and cyclosporine.

  1996cites this paper
• The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse.

  1996cites this paper
• Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.

  1995cites this paper
• Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A.

  1995cites this paper
• Small bowel transplantation. The effect of intraportal donor-specific transfusion 24 hours pretransplant and low-dose cyclosporine.

  1994cites this paper
• Variable prolongation of cardiac allograft survival following intraportal administration of donor antigens.

  1994cites this paper
• The effect of transfusion with donor-specific peripheral lymphocytes, whole blood or erythrocytes on cardiac allograft survival in cyclosporine-treated rats.

  1994cites this paper
• Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.

  1994cites this paper
• Lipid mediated modification of rat heart allograft survival

  1994cites this paper
• Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio.

  1994cites this paper
• Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.

  1993cites this paper
• Failure of azathioprine and steroids to augment one-day-pretransplant donor-specific transfusion-enhanced allograft survival.

  1993cites this paper
• A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.

  1993cites this paper
• Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.

  1992cites this paper
• Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.

  1992cites this paper
• Effects of pre- and postengraftment donor-specific transfusions and cyclosporine on the enhancement of experimental allograft survival.

  1992cites this paper
• The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial.

  1992cites this paper
• Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporine.

  1991cites this paper
• Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.

  1991cites this paper
• Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative period.

  1991cites this paper
• Mechanisms of transfusion‐induced immunosuppression

  1990cites this paper
• The effect of high lipid diet on in vitro prostaglandin E2 and thromboxane B2 production by splenic macrophages.

  1990cites this paper
• Variable infection risk following allogeneic blood transfusions.

  1990cites this paper